Deadline: 24-Aug-20
The Southern African Development Community (SADC) has announced a call for proposals for the support for innovative projects for the production of covid-19 relevant medical and pharmaceutical products (CMPP).
The CMPP Project intervention is a component of the overall project “Support towards Industrialization and the Productive Sectors in the SADC region (SIPS).” The SIPS project is managed and implemented by the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH and is a component of the programme “Cooperation for the Enhancement of SADC Regional.
Objectives
- The CMPP Project has been designed to assist in the fight against the COVID-19 pandemic in the SADC region through providing support to the local production of relevant items to increase their supply in the SADC region, in view of the increased demand due to the pandemic.
- The objective of this project is therefore to support the increased production, supply, and availability of affordable and innovative products to combat the COVID-19 pandemic in the SADC countries.
Funding Information
- The financial grant per successful single applicant is expected to range from EUR 50,000 to EUR 100,000 for for-profit companies, and from EUR 100,000 to EUR 200,000 for non-profit making initiatives.
Scope of Supported Projects
The call supports innovative projects which increase local production in SADC of high-quality products with increased need in relation to the prevention, diagnosis or treatment of COVID-19. This includes but is not limited to:
- PPE including disposable medical masks, N95/ FFP2 masks, face shields, and other essential related items:
- Ventilator project
- Disinfectants and sanitizers
- Diagnostics
- Pharmaceuticals and medicines, which are specifically for COVID-19 treatment, prevention and management (see section 12 g) below)
- The project is expected to contribute to the Sustainable Development Goals (SDGs), in particular SDG 3 – “Ensure healthy lives and promote well-being for all at all ages” and the SADC Industrialization Strategy and Roadmap 20152063 (SISR) goal.
Expected Impact of Supported Projects
The project concept must offer potential development benefits to SADC countries (e.g. establishment of new technologies, novel trade opportunities, increased quality of products, etc.) and their citizens, and should not simply constitute an investment in the company’s actual core business. The project should deliver a significant impact in one or more areas directly related to the current COVID-19 pandemic, and its effects in SADC. This includes the following potential areas:
- Increased local production of affordable, high-quality and innovative products to combat the COVID-19 pandemic in SADC member states
- Increased affordable supply and availability of such products for the SADC population
- Increased protection of health workers, essential services workers and/or the general public
- Increased reduction of disease transmission and/ or infection
- Supporting/ facilitating improved management of COVID-19.
Timeframe
- Support will be awarded to projects that have a maximum implementation period of 12 months (i.e. the period from project initiation to project completion is not longer than 12 months).
Eligibility Criteria
Targeted Groups: Applicants may be either for-profit entities (profit making companies) or not-for-profit entities (non-profit making initiatives, such as University initiatives or national technology initiatives) in the SADC region with innovative projects for the manufacturing of COVID-19-relevant medical, pharmaceutical or PPE products.
- For-Profit Company:
- For companies to be eligible for consideration under the CMPP project, the following criteria must be met. These should be demonstrated, to the satisfaction of the SIPS project management team, including, where relevant, provision of necessary supporting documentation:
- The company or organisation must be officially registered and legally authorized to operate within one or more of the SADC countries.
- The company cannot be a subsidiary of an EU company
- The company should provide copies of valid company or organisation registration/ licensing and tax clearance certificates.
- Minimum annual turnover: EUR 100,000.
- Minimum number of employees: 8
- At least two years of audited financial statements.
- Company may be privately or publicly owned
- The company must not be involved with trade-in, or production of, banned substances.
- The company should be able to demonstrate compliance with environmental protection measures and relevant national and regional laws.
- The company should be able to demonstrate non-discrimination in terms of gender and disadvantaged groups
- For companies to be eligible for consideration under the CMPP project, the following criteria must be met. These should be demonstrated, to the satisfaction of the SIPS project management team, including, where relevant, provision of necessary supporting documentation:
- Non-Profit Making Initiative:
- For initiatives to be eligible for consideration under the CMPP project, the following criteria must be met. These should be demonstrated, to the satisfaction of the SIPS project management team, including where relevant, provision of necessary supporting documentation:
- The initiative has to be 100% not-for-profit.
- The initiative must be officially registered and legally authorized to operate within one or more of the SADC countries.
- The initiative should provide copies of valid registration and/or operation/ licensing and tax clearance certificates.
- Minimum number of direct/indirect employees: 8.
- The initiative may be privately or publicly owned.
- The initiative must not be involved with trade-in, or production of, banned substances.
- The initiative should be able to demonstrate compliance with environmental protection measures and relevant national and regional laws
- The initiative should be able to demonstrate non-discrimination in terms of gender and disadvantaged groups.
- For initiatives to be eligible for consideration under the CMPP project, the following criteria must be met. These should be demonstrated, to the satisfaction of the SIPS project management team, including where relevant, provision of necessary supporting documentation:
Eligible Countries
- Projects in all SADC countries will be considered, therefore: Angola, Botswana, Comoros, Eswatini, DRC, Lesotho, Madagascar, Malawi, Mozambique, Mauritius, Namibia, Seychelles, South Africa, Tanzania, Zambia, Zimbabwe.
For more information, visit https://www.sadc.int/opportunities/procurement/open-procurement-opportunities/project-production-covid-19-relevant-medical-and-pharmaceutical-products/
